Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Sep 30, 2027 → Jan 30, 2028
See other at-risk trials from Brigham and Women's Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Lead sponsor: Brigham and Women's Hospital to Brigham and Women's Hospital Show 4 more changesShow less
    • Start date: Aug 1, 2026 to Jan 1, 2027
    • Primary completion pushed from Sep 30, 2027 to Jan 30, 2028
    • Study completion pushed from Nov 30, 2027 to Mar 30, 2028
    • Eligibility criteria expanded, about 13 words
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Acupuncture points or acupoints are fundamental to the practice of acupuncture, yet their scientific basis remains unclear. According to traditional explanations of acupuncture, acupoints can become tender or more sensitive to pressure when there is an underlying disease of the body. Findings from recent basic animal studies support this traditional theory. For example, compared to healthy control animals, models of colitis have shown increased skin temperature, blood flow, and pain sensitivity at specific body regions that correspond to the location of acupoints that are commonly used in acupuncture treatment for colitis. However, little is known about whether these findings apply to humans.
Trial Details
NCT Number NCT07681895
Lead Sponsor Brigham and Women's Hospital
Collaborators: National Center for Complementary and Integrative Health (NCCIH)
Conditions
(from sponsor)
Inflammatory Bowel Disease (IBD)
Related terms Inflammatory Bowel Diseases
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov